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INTRODUCTION
Spine surgery presents some challenges to the 
anesthesiologist. Patients underwent spinal surgery 
such as microdiscectomy, reconstructive surgery, 
decompression surgery, vertebral fracture fixation, 
or debridement fixation may result in significant 
intraoperative blood loss and postoperative acute 
pain.1
The significance of reducing the bleeding on 
spinal surgery is not only important for maintain-
ing the patient’s hemodynamic stability but also 
enables a better surgical field, with all its fragile, 
major neurological structures. Maintaining a clear 
surgical field helps the surgeon to reduce surgery 
time, which in turn reduces the total blood loss, 
thus maintaining a better hemodynamic stability. 
Hemodynamic stability in spinal surgery is 
desirable to perform rapid recovery for early 
neurologic assessment and management of compli-
cations. It is therefore mandatory for anesthesiolo-
gists to choose techniques that allow hemodynamic 
stability during the procedure.2 The alpha-2 agonist 
group is a new class of drugs with different mech-
anisms of action from other commonly used anes-
thetic agents. Dexmedetomidine (DEX) is one of 
the most potent and highly selective α2-adrenergic 
receptor agonists, with an affinity for α2:α1 recep-
tor bindings in the ratio of 1,620:1. DEX possesses 
a hypnotic, sedative, anxiolytic, sympatholytic, and 
analgesic properties without producing significant 
respiratory depression.3 Its central and peripheral 
sympatholytic actions are mediated by binding 
to the alpha-2 adrenergic receptors resulting in 
decreased mean arterial pressure (MAP), heart rate 
(HR), cardiac output, and norepinephrine release.2
Another alpha-2 adrenergic agonist group is 
clonidine. Clonidine has sedative, analgesic, and 
anti-anxiety effects decreases the need for anes-
thetic drugs and maintaining perioperative hemo-
dynamic stability and sympathoadrenal stability.4-6
Despite some clinical trials that study the effec-
tiveness of DEX and clonidine in reducing intra-
operative bleeding in adults, only little is known 
about their effects in maintaining intraoperative 
hemodynamics in spinal surgery.2 It is well-known 
that spinal surgery has many complications such 
as postoperative hematoma development, recur-
rent laryngeal nerve paralysis (RLN), and vascular 
damage.7,8 The goal of this study was to compare 
the effect of DEX and clonidine as adjuvants in 
anesthesia in providing hemodynamic stability in 
patients undergoing spinal surgery.
PATIENTS AND METHODS
This is an observational cohort study. 30 patients 
were enrolled in this study by consecutive sampling. 
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ABSTRACT
Introduction: Spine surgery presents a number of challenges to the 
anesthesiologist. The α
2
 adrenergic agonist drugs are commonly used 
in such cases to provide hemodynamic and sympathoadrenal stability. 
Dexmedetomidine (DEX) is one of the most potent and highly selective 
α
2
-adrenergic receptor agonists. Another α
2
 adrenergic agonist drug 
that is used widely is clonidine. The study aims to compare both drugs 
in terms of hemodynamic stability in spine surgeries.
Patients and Methods: 30 patients underwent spinal surgery were 
classified into one of the following group: DEX group (received DEX 
1 mcg/kg in 10 minutes followed by 0.5 mcg/kg/hour during the 
course of the surgery) or CLO group (received clonidine 1 mcg/kg in 10 
minutes followed by 1 mcg/kg/hour during surgery), by consecutive 
sampling. All other treatments and medications were similar in 
both groups. The systolic and diastolic blood pressure, mean arterial 
pressure, and heart rate were recorded every 5 minutes. Data was 
then analyzed by SPSS. 
Result: The patients in the DEX group had a better mean arterial 
pressure (p=0.002) and heart rate (p=0.018) stability compared to 
those in the CLO group.
Conclusion: The administration of dexmedetomidine provides a 
better hemodynamic stability compared to clonidine in patients 
underwent spinal surgery. 
Keywords: Spine surgery, Dexmedetomidine, Clonidine, Hemodynamic Stability.
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This study was approved by the Committee of 
Ethical Research of Udayana University/Sanglah 
Hospital. All subjects provided a written consent to 
be included in this study. 
Inclusion criteria include those aged 18-65 years 
old, body mass index (BMI) 18.5-23.0 kg/m2, phys-
ical status ASA I-II, who underwent spinal surgery. 
And the exclusion criteria were those whose history 
of allergy to anesthetic drugs, those whose history 
of allergy to alpha-2 agonist drugs, those with a 
history or presenting heart and/or vascular disease, 
pregnancy, those with a history of hypertension, 
and eventful surgery (i.e. massive bleeding). 
Patients who met eligibility criteria were 
randomly divided into 2 groups, the dexmedetomi-
dine group (DEX group) and the clonidine group 
(CLO group). The patients in the DEX group were 
given dexmedetomidine 1 mcg/kg in 10 minutes, 
followed by maintenance dose at 0.5 mcg/kg/hour 
during the course of the surgery, until the skin 
closure was completed. Those in the CLO group 
were given clonidine 1mcg/kg in 10 minutes, 
followed by maintenance dose at 1 mcg/kg/hour 
during the course of the surgery, until the skin 
closure was completed. The hemodynamic status 
data were recorded every five minutes. They include 
the systolic blood pressure (SBP), diastolic blood 
pressure (DBP), mean arterial pressure (MAP), and 
heart rate (HR).
Otherwise, all medications used for all patients 
in both groups were the same. Those include ringer 
lactate infusion 3 ml/kg in 20 minutes, midazolam 
0.05 mg/kg, fentanyl 2 mcg/kg, propofol 2.5 mg/kg, 
and atracurium 0.5 mg/kg. We use standard ASA 
monitoring devices like sphygmomanometer, 
peripheral oxygen saturation, bispectral index, 
ECG, end-tidal CO2 (EtCO2), and oral tempera-
ture. All patients involved were mechanically venti-
lated (tidal volume of 6-8 ml/kg, respiration rate 
at 12-16 with targeted EtCO2 30-35 mmHg), and 
anesthesia was maintained using compressed air 
at 2 liters per minute (LPM), oxygen 2 LPM, and 
sevoflurane 1.5-2.5% (using targeted BIS at 40-55).
We used SPSS 22.0 for data analysis. Shapiro-
Wilk, Mann-Whitney, independent t, Levene, and 
chi-square tests were used in the analysis, where 
a p-value of <0.05 was considered statistically 
significant. 
RESULTS
30 patients were enrolled for this study, with a 
group consisted of 15 subjects. The median age for 
the DEX group was 46, compared to 55 in the CLO 
group. The subjects’ characteristics are shown in 
Table 1. 
Significant differences in the MAP were found 
in the 10th minute, which was the time where the 
full dose of the loading dose of dexmedetomidine 
or clonidine was administered (95.3 ± 4.8 vs. 84.1 ± 
6.9, p <0.001). The difference between MAP and 
HR in both groups were shown in Table 2 and 
Table  3, respectively. Figures 1 and 2 displayed a 
pattern where it is visible that dexmedetomidine 
provides a better MAP and HR stability compared 
to clonidine. 
Figure 1 MAP comparison trend
Figure 2 HR comparison trend
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DISCUSSION
Reid and Brace9 first described the hemodynamic 
response that occurs during laryngoscopy and 
intubation in the form of elevated blood pressure, 
tachycardia, coughing reflex, increased intra-
cranial, and increased intraocular pressure. The 
perioperative stress associated with surgery and 
anesthesia results in an endocrine response that 
stimulates the sympathetic nervous system, where 
plasma adrenaline concentration will increase as 
arterial pressure, heart rate, and O2 consumption 
increase. This adverse hemodynamic response can 
affect the outcome of the patient. Thus, attention 
Table 1  Subjects’ characteristic
Variables
Groups
DEX (N=15) CLO (N=15)
Age, years (median(IQR) 46 (32) 55 (21)
Gender
Male, n(%) 10 (66.7) 13 (86.7%)
Female, n(%) 5 (33.3) 2 (13.3%)
BMI, kg/m2 (mean±SD) 22.4±2.9 23.3±3.3
ASA
I 1 (6.7) 1 (6.7)
II 14 (93.3) 14 (93.3)
Surgery duration, minutes (median, IQR) 175 (70) 145 (75)
Table 2  MAP comparison of both groups
MAP 
Group
p-value Mean difference CI (95%)DEX (n=15) CLO (n=15)
Baseline 102.5 ± 6.4 100.0 ± 6.3 0.283 2.533 -2.209 - 7.276
5 99.3 ± 5.9 87.5 ± 6.3 0.000 11.733 7.173 - 16.293
10a 95.3 ± 4.8 84.1 ± 6.9 0.000 11.200 6.739 - 15.661
15b 93.5 ± 4.6 92.9 ± 7.5 0.793 0.600 -4.044 - 5.244
20 91.9 ± 5.4 97.9 ± 7.9 0.022 -6.000 -11.077 - -0.923
25 90.8 ± 4.9 94.8 ± 7.1 0.087 -3.933 -8.483 - 0.617
30c 90.1 ± 5.2 86.2 ± 6.4 0.076 3.933 -0.442 - 8.309
35 89.5 ± 5.2 79.6 ± 5.2 0.000 9.933 6.054 - 13.813
40 87.9 ± 5.2 77.8 ± 6.6 0.000 10.133 5.669 - 14.597
45 87.9 ± 4.2 78.1 ± 6.8 0.000 9.800 5.586 - 14.014
50 87.3 ± 4.3 74.4 ± 6.1 0.000 12.933 8.973 - 16.894
55 87.4 ± 4.5 74.7 ± 7.7 0.000 12.667 7.943 - 17.390
60 87.8 ± 4.1 74.9 ± 7.3 0.000 12.867 8.421 - 17.313
65 86.7 ± 4.4 78.3 ± 7.3 0.001 8.467 3.939 - 12.994
70 86.2 ± 4.7 79.2 ± 6.9 0.003 7.000 2.587 - 11.413
75 86.7 ± 4.4 76.0 ± 5.5 0.000 10.667 6.923 - 14.410
80 86.1 ± 5.2 74.9 ± 6.8 0.000 11.200 6.693 - 15.707
85 85.8 ± 5.6 73.7 ± 6.2 0.000 12.133 7.704 - 16.562
90 86.1 ± 5.1 74.3 ± 5.8 0.000 11.800 7.733 - 15.867
95 86.4 ± 5.5 77.1 ± 7.2 0.000 9.267 4.454 - 14.080
100 86.5 ± 6.4 82.0 ± 6.9 0.078 4.467 -0.526 - 9.460
105 86.0 ± 5.9 88.9 ± 7.2 0.243 -2.867 -7.795 - 2.062
aAfter DEX/CLO administration bTime of induction cStart of surgery
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to the response is essential to reduce perioperative 
morbidity and mortality.
Arora10 and Wijeysundera11 reported that a 
temporary increase in heart rate within 3-5 minutes 
of dexmedetomidine administration would be 
followed by a decrease in heart rate, possibly 
because the vasoconstriction effect occurs earlier 
than the central sympathetic response. Scheinin12 
showed that dexmedetomidine reduces the cardio-
vascular response to laryngoscopy and intubation 
by measuring catecholamine concentrations and 
found that noradrenaline concentrations in plasma 
are less in the dexmedetomidine group in all induc-
tion phases.
In our observations, we found significant differ-
ences in the MAP between the dexmedetomidine 
and clonidine groups after the administration of the 
loading dose of the alpha-2 agonists (95.3±4.8 vs. 
84.1±6.9, p <0.001) and upon induction (93.5 ± 4.6 
vs. 92.9±7.5, p <0.001), all in favor to the dexmede-
tomidine group. These significant differences in the 
MAP then rose again in minutes 35-95. 
The significant differences in heart rate were 
found after the administration of the loading dose 
of the alpha-2 agonists (80.5±4.5 vs. 68.5±6.5), 
upon induction (79.9±4.2 vs. 67.7±5.4), and upon 
intubation (79.0±4.6 vs. 67.1±7.5), all in favor to 
the dexmedetomidine group. The significant differ-
ences in heart rate went on until minute 70. 
Clonidine and dexmedetomidine are both α2 
agonists that vary in terms of potential and affinity 
for different types of α2 receptors. Clonidine has a 
specificity of 220:1 (α2: α1), whereas dexmedeto-
midine of 1620:1.5 Dexmedetomidine is a phar-
macologically active dose of medetomidine, a total 
agonist of the α2 adrenergic receptor.
Clonidine is used to decrease the systemic 
blood pressure through central brain stem adren-
ergic stimulation. Clonidine is rapidly and almost 
entirely absorbed after oral administration, and 
may show a temporary increase in blood pressure 
after the initial dose due to mild stimulation of the 
peripheral post-junctional α1 receptor.6,13
Dexmedetomidine shows biphasic blood pres-
sure response in a dose-dependent manner.14 A low 
dose of intravenous infusion results in a reduction 
of mean arterial pressure due to selectivity for 
central and peripheral α2 receptors. This leads to 
Table 3 HR comparison based on both groups
HR 
Groups
p-value
Mean 
difference CI (95%)DEX (n=15) CLO (n=15)
Baseline 85.0 ± 6.7 79.7 ± 5.6 0.025 5.333 0.715 - 9.951
5 82.3 ± 4.5 70.2 ± 6.3 0.000 12.067 8.006 - 16.128
10a 80.5 ± 4.5 68.5 ± 6.5 0.000 12.000 7.822 - 16.178
15b 79.9 ± 4.2 67.7 ± 5.4 0.000 12.133 8.517 - 15.750
20 79.0 ± 4.6 67.1 ± 7.5 0.000 9.933 5.290 - 14.576
25 77.7 ± 4.8 70.7 ± 7.3 0.004 7.067 2.455 - 11.678
30c 75.9 ± 5.0 66.3 ± 7.0 0.000 9.533 4.968 - 14.099
35 75.5 ± 5.5 65.7 ± 5.1 0.000 9.800 5.839 - 13.761
40 74.3 ± 4.5 66.1 ± 4.8 0.000 8.200 4.709 - 11.691
45 74.0 ± 4.3 69.2 ± 5.3 0.011 4.800 1.190 - 8.410
50 74.1 ± 6.5 67.7 ± 6.7 0.013 6.333 1.421 - 11.246
55 72.3 ± 5.2 67.2 ± 6.1 0.019 5.133 0.893 - 9.373
60 72.4 ± 5.6 67.1 ± 6.4 0.022 5.333 0.831 - 9.373
65 72.6 ± 5.2 68.9 ± 6.4 0.028 3.667 -0.719 - 8.052
70 72.5 ± 5.9 67.3 ± 6.5 0.032 5.133 0.477 - 9.790
75 72.3 ± 7.4 69.1 ± 7.4 0.247 3.200 -2.345 - 8.745
80 72.3 ± 7.0 70.3 ± 7.5 0.473 1.933 -3.509 - 7.375
85 71.5 ± 6.8 70.6 ± 5.8 0.711 0.867 -3.879 - 5.613
90 72.0 ± 6.1 69.1 ± 6.4 0.219 2.867 -1.808 - 7.541
95 70.9 ± 6.5 70.3 ± 6.5 0.802 0.600 -4.256 - 5.456
100 71.3 ± 6.7 71.9 ± 7.1 0.833 -0.533 -5.671 - 4.604
105 72.2 ± 6.2 74.7 ± 7.1 0.305 -2.533 -7.502 - 2.435
aAfter DEX/CLO administration bTime of induction cStart of surgery
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a decrease in heart rate and systemic blood vessel 
resistance indirectly decreases cardiac output and 
systolic blood pressure. While high doses of intra-
venous infusion or rapid intravenous bolus admin-
istration may lead to systemic hypertension due 
to the activation of peripheral α1 post-junctional 
adrenergic receptors. 
Dexmedetomidine loses the selectivity of α2 
receptors as dosage increases through intrave-
nous bolus injection or rapid infusion. This loss 
of selectivity results in an initial increase in blood 
pressure and decreased heart rate simultaneously, 
which returns normally within 15 minutes.15 
Hypertension can also be observed because of the 
temporary activation of peripheral α2B receptors at 
the time of rapid bolus injection of the drug. This 
brief increase in blood pressure may be due to the 
remarkable effects of competition with the vaso-
dilatory effects of the central α2A receptor.16 These 
effects help modulate the stress response, increase 
the stability, and can protect against radical fluctu-
ations in intraoperative cardiovascular parameters.
CONCLUSION
We found significant differences in hemodynamic 
stability in both groups, where both dexmedeto-
midine and clonidine were used as an adjuvant 
in anesthesia. Dexmedetomidine provides better 
MAP and heart rate stability than clonidine in 
patients undergoing spine surgery.
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